Middle East & Africa Atrial Fibrillation Surgery Market

Middle East & Africa Atrial Fibrillation Surgery Market Size & Growth (2023 to 2028)

The Size of the Middle East & Africa Atrial Fibrillation Surgery Market is valued at USD 0.12 billion in 2023 and is projected to reach USD 0.27 billion by 2028, increasing at a CAGR of 16.2% during the forecast period 2023 to 2028.

Increased prevalence of atrial fibrillation is a crucial driving factor in the MEA region, which is likely to promote market growth. In addition, atrial fibrillation's prevalence in various socio-economic areas in UAE and Kuwait and its link to stroke will boost the market growth.

The factor that drives the market expansion is the increase in the geriatric population during the predicted period. Moreover, the technological improvements will fuel market expansion.

Furthermore, the growth of the Middle East and Africa atrial fibrillation market is likely to be aided by an increase in the adoption of closure devices for treating atrial fibrillation. In addition, an increase in research and development activities is projected to provide attractive growth prospects for the market.

Another essential element driving this market is the rise in persons suffering from atrial fibrillation. 

In addition, the increasing number of atrial fibrillation surgical and catheter ablation operations is propelling the expansion of this market due to a higher prevalence of atrial fibrillation and lower treatment costs.

The high cost of atrial fibrillation surgery is the patient bears that impede the atrial fibrillation market's growth. For instance, the Food and Drug Administration issued Medtronic a recall for cardiac pacemakers it had put on the market. Furthermore, a scarcity of qualified personnel will stymie market expansion.

This research report on the Middle East &Africa Atrial Fibrillation Surgery Market has been segmented and sub-segmented into the following categories.

By Surgical Procedure:

• Catheter Ablation procedure
• Surgical Ablation
• Maze procedure

By Product:

• Catheter Ablation
• Surgical Ablation

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the Middle East & Africa Atrial Fibrillation Surgery Market has a moderate part of the market globally due to an increase in surgery. However, patients with cardiovascular problems are at high risk. They are especially prone to numerous organ failures, including myocarditis and rhythm disturbances, throughout the Middle East and Africa, where nations like UAE and Kuwait dominate the revenue share.

According to another regional perspective, arrhythmia and acute cardiac damage were among the most common heart problems in confirmed-positive covid patients. But, again, patients who got care in the ICU were more likely to develop one of these problems than patients who did not get care in the ICU.

Furthermore, remote monitoring enables clinicians to retain the necessary patient connection with their healthcare provider due to the escalating public health issue. Healthcare providers can obtain information about a patient's health remotely while at home, reducing the hospital visits & lowering the danger of infection from influenza viruses.

New technologies and digital platforms aid in remote care should be created in UAE. More study on the function of telehealth, continuous data collection, sophisticated automobile features, and remote patient monitoring is needed to advise best practices that might fuel the market's growth.

KEY MARKET PLAYERS

Key market participants dominating the Middle East & Africa Atrial Fibrillation Surgery Market profiled in the Report are Cardiofocus, Inc., nContact, Inc., Biosense Webster, Inc., Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Articure, Inc., Cardima, Inc. and Biotronik SE & Co.,